Medication to stop breast milk after 16–20 week abortion
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests a medication given after a second-trimester abortion (16–20 weeks) to see if it can safely and effectively stop the body from producing breast milk. It also wants to learn how well people tolerate the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are pregnant and planning an abortion between 16 weeks and 20 weeks of pregnancy (or are managing a pregnancy loss at that stage).
- You can read and sign a consent form in English.
- You do not have high blood pressure, heart valve problems, lung scarring, bipolar disorder, or schizophrenia.
- You are not allergic to the study drugs or to lactose (the placebo contains lactose).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining two medications (lidocaine and ketorolac) given as a shot around the cervix can help with pain when placing small sticks (dilators) to prepare for an abortion procedure. If you are 16–24 weeks pregnant and planning an abortion, this trial may help you feel less discomfort.
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This trial tests a medication called misoprostol to help the body expel pregnancy tissue after a fetal death between 18 and 24 weeks. It may be an option for women who have not had a previous C-section or have had only one.
Hear when a new Lactation Suppressed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.